Research & Development
6 March 2026 - Healthcare products company Johnson & Johnson (J&J) (NYSE:JNJ) announced on Thursday that it has received approval from the US Food and Drug Administration (FDA) for its TECVAYL...
5 March 2026 - Airiver Medical, a clinical stage company developing technologies to help patients who suffer from certain respiratory tract conditions, announced on Wednesday that it has received Brea...
3 March 2026 - Sanaregen Vision Therapeutics, a clinical-stage regenerative medicine company, on Tuesday announced US Food and Drug Administration (FDA) clearance to begin a Phase I/II clinical trial ...
3 March 2026 - US commercial stage biopharmaceutical company Esperion Therapeutics Inc (NASDAQ:ESPR) on Tuesday announced a definitive agreement to acquire privately held Corstasis Therapeutics Inc, a...